Skip to content

Pain Responses in Patients on Long-Term Opioid Therapy for Chronic Pain

CompletedNCT00656942
View the official record on ClinicalTrials.gov

Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.

This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.

Brief summary (from the registry)

The MGH Center for Translational Pain Research is seeking patients with chronic pain for a research study. The study is looking at the effect of opioid (narcotic) pain medicines on pain sensation, threshold and tolerance.

Study details

Official title
Pain Responses in Patients on Long-Term Opioid Therapy for Chronic Pain
Conditions
Interventions
  • Device: Quantitative Sensory Testing (QST)
Sponsor
Massachusetts General Hospital
Start date
2006-07
Primary completion
2013-10
Sex
All
Age range
from 18 Years to 65 Years
Results posted
No results posted in this snapshot
Countries
United States
Total sites listed
1

Eligibility criteria

Show eligibility criteria (verbatim from the registry)
a. Inclusion/exclusion criteria Inclusion Criteria for the group with chronic pain on chronic treatment with opioids: 1. Subject has chronic pain and is on stable chronic opioid treatment (morphine, fentanyl, oxycodone, methadone, hydromorphone, hydrocodone) for chronic pain for at least one month. We consider stable treatment if no change in the type and amount of daily opioid treatment for one month. Only patients with minimal daily opioid dose of at least 30 mg morphine equianalgesic dose will be included. 2. Subject is age 18 to 65 years. Inclusion Criteria for the group with chronic pain on chronic treatment with non-opioids (currently not recruiting): 1. Subject has pain and is on stable chronic non-opioid treatment for chronic pain for at least one month. 2. Subject is age 18 to 65 years. Inclusion Criteria for the group of opioid-naive healthy volunteers without chronic pain (currently not recruiting): 1. Subject is opioid naive meaning he/she did not receive chronic opioid treatment in the past or present, and did not receive acute treatment with opioids in the last 1 month 2. Subject does not have pain 3. Subject is age 18 to 65 years. Exclusion Criteria for all groups: 1. Subject has lost tactile sensation in the sites for QST testing (upper extremities) 2. Subject has scar tissue or acute injury in the skin areas for QST testing (upper extremities) 3. Subject has neurological disease or a medical condition causing peripheral polyneuropathy and sensory changes (including but not limited to diabetes, alcoholism, AIDS, thyroid disease, liver or kidney disorders). It is the presence of neuropathy, not the causative disease itself, that is the exclusion criteria. 4. Subject had recent therapy that may influence QST results, e.g., neuroablative procedure involving upper extremities within six-months; peripheral neurolytic block within two-months; injection therapy for pain within four-weeks; sympathetic block within six months. 5. Subject has litigation pending relative to their chronic pain. 6. Subject has major psychiatric disorder (major depression disorder; bipolar disorder; schizophrenia; anxiety disorder; psychotic disorders; eating disorders; alcohol or drug dependence; attention deficit hyperactivity disorder); any known history of these conditions will exclude participation. 7. Subject has used illicit drugs within past 6 months. 8. Subject is pregnant

Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT00656942